Gene symbol: Ptch1

Also known as: Ptch; Ptch2

Organism: Rattus norvegicus

Summary: Predicted to enable several functions, including cholesterol binding activity; cyclin binding activity; and signaling receptor binding activity. Involved in several processes, including commissural neuron axon guidance; gland development; and response to estradiol. Located in growth cone; nucleus; and postsynaptic density. Human ortholog(s) of this gene implicated in basal cell carcinoma; holoprosencephaly; holoprosencephaly 7; and nevoid basal cell carcinoma syndrome. Orthologous to human PTCH1 (patched 1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 89830 Ensembl:ENSRNOG00000019354 AllianceGenome:RGD:621425


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0000578 Embryonic axis specification
Process GO:0000902 Cell morphogenesis
Process GO:0000904 Cell morphogenesis involved in differentiation
Process GO:0001655 Urogenital system development
Process GO:0001656 Metanephros development
Process GO:0001657 Ureteric bud development
Process GO:0001658 Branching involved in ureteric bud morphogenesis
Process GO:0001701 In utero embryonic development
Process GO:0001708 Cell fate specification
Process GO:0001709 Cell fate determination
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001822 Kidney development
Process GO:0001823 Mesonephros development
Process GO:0001838 Embryonic epithelial tube formation
Process GO:0001840 Neural plate development
Process GO:0001841 Neural tube formation
Process GO:0001843 Neural tube closure
Process GO:0001889 Liver development
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0003002 Regionalization
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003007 Heart morphogenesis
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006508 Proteolysis
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006935 Chemotaxis
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007224 Smoothened signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007276 Gamete generation
Process GO:0007281 Germ cell development
Process GO:0007283 Spermatogenesis
Process GO:0007286 Spermatid development
Process GO:0007346 Regulation of mitotic cell cycle
Process GO:0007389 Pattern specification process
Process GO:0007399 Nervous system development
Process GO:0007409 Axonogenesis
Process GO:0007411 Axon guidance
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007507 Heart development
Process GO:0008104 Protein localization
Process GO:0008152 Metabolic process
Process GO:0008283 Cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008544 Epidermis development
Process GO:0008589 Regulation of smoothened signaling pathway
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009612 Response to mechanical stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009798 Axis specification
Process GO:0009880 Embryonic pattern specification
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009913 Epidermal cell differentiation
Process GO:0009953 Dorsal/ventral pattern formation
Process GO:0009957 Epidermal cell fate specification
Process GO:0009966 Regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010157 Response to chlorate
Process GO:0010467 Gene expression
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010646 Regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010837 Regulation of keratinocyte proliferation
Process GO:0010839 Negative regulation of keratinocyte proliferation
Process GO:0010874 Regulation of cholesterol efflux
Process GO:0010875 Positive regulation of cholesterol efflux
Process GO:0014020 Primary neural tube formation
Process GO:0014070 Response to organic cyclic compound
Process GO:0016043 Cellular component organization
Process GO:0016331 Morphogenesis of embryonic epithelium
Process GO:0016485 Protein processing
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019953 Sexual reproduction
Process GO:0021510 Spinal cord development
Process GO:0021515 Cell differentiation in spinal cord
Process GO:0021517 Ventral spinal cord development
Process GO:0021522 Spinal cord motor neuron differentiation
Process GO:0021532 Neural tube patterning
Process GO:0021904 Dorsal/ventral neural tube patterning
Process GO:0021915 Neural tube development
Process GO:0021953 Central nervous system neuron differentiation
Process GO:0021997 Neural plate axis specification
Process GO:0022008 Neurogenesis
Process GO:0022412 Cellular process involved in reproduction in multicellular organism
Process GO:0022414 Reproductive process
Process GO:0022612 Gland morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030030 Cell projection organization
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030326 Embryonic limb morphogenesis
Process GO:0030850 Prostate gland development
Process GO:0030855 Epithelial cell differentiation
Process GO:0030856 Regulation of epithelial cell differentiation
Process GO:0030858 Positive regulation of epithelial cell differentiation
Process GO:0030879 Mammary gland development
Process GO:0031099 Regeneration
Process GO:0031100 Animal organ regeneration
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0032355 Response to estradiol
Process GO:0032368 Regulation of lipid transport
Process GO:0032370 Positive regulation of lipid transport
Process GO:0032371 Regulation of sterol transport
Process GO:0032373 Positive regulation of sterol transport
Process GO:0032374 Regulation of cholesterol transport
Process GO:0032376 Positive regulation of cholesterol transport
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032526 Response to retinoic acid
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0033036 Macromolecule localization
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033993 Response to lipid
Process GO:0035107 Appendage morphogenesis
Process GO:0035108 Limb morphogenesis
Process GO:0035113 Embryonic appendage morphogenesis
Process GO:0035137 Hindlimb morphogenesis
Process GO:0035148 Tube formation
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0036314 Response to sterol
Process GO:0036315 Cellular response to sterol
Process GO:0040008 Regulation of growth
Process GO:0040011 Locomotion
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0040015 Negative regulation of multicellular organism growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042330 Taxis
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0043009 Chordate embryonic development
Process GO:0043170 Macromolecule metabolic process
Process GO:0043433 Negative regulation of DNA-binding transcription factor activity
Process GO:0043616 Keratinocyte proliferation
Process GO:0044092 Negative regulation of molecular function
Process GO:0044238 Primary metabolic process
Process GO:0045165 Cell fate commitment
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045604 Regulation of epidermal cell differentiation
Process GO:0045606 Positive regulation of epidermal cell differentiation
Process GO:0045667 Regulation of osteoblast differentiation
Process GO:0045668 Negative regulation of osteoblast differentiation
Process GO:0045682 Regulation of epidermis development
Process GO:0045684 Positive regulation of epidermis development
Process GO:0045879 Negative regulation of smoothened signaling pathway
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045926 Negative regulation of growth
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0048232 Male gamete generation
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048515 Spermatid differentiation
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048568 Embryonic organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048598 Embryonic morphogenesis
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048638 Regulation of developmental growth
Process GO:0048640 Negative regulation of developmental growth
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048666 Neuron development
Process GO:0048667 Cell morphogenesis involved in neuron differentiation
Process GO:0048699 Generation of neurons
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048736 Appendage development
Process GO:0048745 Smooth muscle tissue development
Process GO:0048754 Branching morphogenesis of an epithelial tube
Process GO:0048812 Neuron projection morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048858 Cell projection morphogenesis
Process GO:0048869 Cellular developmental process
Process GO:0048878 Chemical homeostasis
Process GO:0050673 Epithelial cell proliferation
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050680 Negative regulation of epithelial cell proliferation
Process GO:0050789 Regulation of biological process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051179 Localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051302 Regulation of cell division
Process GO:0051604 Protein maturation
Process GO:0051641 Cellular localization
Process GO:0051668 Localization within membrane
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051782 Negative regulation of cell division
Process GO:0060037 Pharyngeal system development
Process GO:0060173 Limb development
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060322 Head development
Process GO:0060341 Regulation of cellular localization
Process GO:0060429 Epithelium development
Process GO:0060443 Mammary gland morphogenesis
Process GO:0060537 Muscle tissue development
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060603 Mammary gland duct morphogenesis
Process GO:0060606 Tube closure
Process GO:0060644 Mammary gland epithelial cell differentiation
Process GO:0060675 Ureteric bud morphogenesis
Process GO:0060831 Smoothened signaling pathway involved in dorsal/ventral neural tube patterning
Process GO:0060896 Neural plate pattern specification
Process GO:0060993 Kidney morphogenesis
Process GO:0061005 Cell differentiation involved in kidney development
Process GO:0061008 Hepaticobiliary system development
Process GO:0061053 Somite development
Process GO:0061138 Morphogenesis of a branching epithelium
Process GO:0061180 Mammary gland epithelium development
Process GO:0061326 Renal tubule development
Process GO:0061333 Renal tubule morphogenesis
Process GO:0061458 Reproductive system development
Process GO:0061564 Axon development
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070723 Response to cholesterol
Process GO:0070727 Cellular macromolecule localization
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071396 Cellular response to lipid
Process GO:0071397 Cellular response to cholesterol
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071679 Commissural neuron axon guidance
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072001 Renal system development
Process GO:0072006 Nephron development
Process GO:0072009 Nephron epithelium development
Process GO:0072028 Nephron morphogenesis
Process GO:0072044 Collecting duct development
Process GO:0072073 Kidney epithelium development
Process GO:0072078 Nephron tubule morphogenesis
Process GO:0072080 Nephron tubule development
Process GO:0072088 Nephron epithelium morphogenesis
Process GO:0072089 Stem cell proliferation
Process GO:0072091 Regulation of stem cell proliferation
Process GO:0072111 Cell proliferation involved in kidney development
Process GO:0072163 Mesonephric epithelium development
Process GO:0072164 Mesonephric tubule development
Process GO:0072171 Mesonephric tubule morphogenesis
Process GO:0072175 Epithelial tube formation
Process GO:0072203 Cell proliferation involved in metanephros development
Process GO:0072205 Metanephric collecting duct development
Process GO:0072359 Circulatory system development
Process GO:0072657 Protein localization to membrane
Process GO:0072659 Protein localization to plasma membrane
Process GO:0080090 Regulation of primary metabolic process
Process GO:0097305 Response to alcohol
Process GO:0097306 Cellular response to alcohol
Process GO:0097421 Liver regeneration
Process GO:0097485 Neuron projection guidance
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120039 Plasma membrane bounded cell projection morphogenesis
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1905952 Regulation of lipid localization
Process GO:1905954 Positive regulation of lipid localization
Process GO:1990778 Protein localization to cell periphery
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000647 Negative regulation of stem cell proliferation
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0005901 Caveola
Component GO:0005929 Cilium
Component GO:0012505 Endomembrane system
Component GO:0014069 Postsynaptic density
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0030426 Growth cone
Component GO:0030427 Site of polarized growth
Component GO:0030496 Midbody
Component GO:0031224 Intrinsic component of membrane
Component GO:0032279 Asymmetric synapse
Component GO:0036477 Somatodendritic compartment
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0044292 Dendrite terminus
Component GO:0044294 Dendritic growth cone
Component GO:0044295 Axonal growth cone
Component GO:0044853 Plasma membrane raft
Component GO:0045121 Membrane raft
Component GO:0045177 Apical part of cell
Component GO:0045202 Synapse
Component GO:0048471 Perinuclear region of cytoplasm
Component GO:0071944 Cell periphery
Component GO:0097447 Dendritic tree
Component GO:0098590 Plasma membrane region
Component GO:0098794 Postsynapse
Component GO:0098857 Membrane microdomain
Component GO:0098984 Neuron to neuron synapse
Component GO:0099572 Postsynaptic specialization
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001664 G protein-coupled receptor binding
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005113 Patched binding
Function GO:0005119 Smoothened binding
Function GO:0005488 Binding
Function GO:0005496 Steroid binding
Function GO:0005515 Protein binding
Function GO:0005539 Glycosaminoglycan binding
Function GO:0008158 Hedgehog receptor activity
Function GO:0008201 Heparin binding
Function GO:0008289 Lipid binding
Function GO:0015485 Cholesterol binding
Function GO:0030332 Cyclin binding
Function GO:0032934 Sterol binding
Function GO:0036094 Small molecule binding
Function GO:0038023 Signaling receptor activity
Function GO:0043178 Alcohol binding
Function GO:0044877 Protein-containing complex binding
Function GO:0060089 Molecular transducer activity
Function GO:0097108 Hedgehog family protein binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:1901681 Sulfur compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-5358351 Signaling by Hedgehog
RCTM RNO-5610787 Hedgehog off state
RCTM RNO-5632681 Ligand-receptor interactions
RCTM RNO-5632684 Hedgehog on state
RCTM RNO-5635838 Activation of SMO
WikiPathways WP574 Hedgehog signaling pathway
KEGG rno04024 cAMP signaling pathway
KEGG rno04340 Hedgehog signaling pathway
KEGG rno04360 Axon guidance
KEGG rno05200 Pathways in cancer
KEGG rno05205 Proteoglycans in cancer
KEGG rno05217 Basal cell carcinoma

Expression profile of Ptch1 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 3.1068034
GSM2685202 MX2 tissue: Myocardium gender: female 4.059071
GSM2685203 MX3 tissue: Myocardium gender: female 4.0747476
GSM2685204 MX4 tissue: Myocardium gender: male 3.0525439
GSM2685205 DZ1 tissue: Myocardium gender: male 3.7913327
GSM2685206 DZ2 tissue: Myocardium gender: male 4.9672866
GSM2685207 DZ3 tissue: Myocardium gender: female 3.3371565
GSM2685208 DZ4 tissue: Myocardium gender: female 2.9098005
GSM2685209 JJ1 tissue: Myocardium gender: male 2.7026405
GSM2685210 JJ2 tissue: Myocardium gender: female 2.3604646
GSM2685211 JJ3 tissue: Myocardium gender: female 3.1324406
GSM2685212 JJ4 tissue: Myocardium gender: male 2.3247035
GSM2685213 NG1 tissue: Myocardium gender: male 2.7588587
GSM2685214 NG2 tissue: Myocardium gender: female 2.6379995
GSM2685215 NG3 tissue: Myocardium gender: male 3.3917289
GSM2685216 NG4 tissue: Myocardium gender: female 3.1367438
GSM2685217 YL1 tissue: Myocardium gender: male 2.3701637
GSM2685218 YL2 tissue: Myocardium gender: male 2.740888
GSM2685219 YL3 tissue: Myocardium gender: female 3.3906634
GSM2685220 YL4 tissue: Myocardium gender: female 2.5710938
GSM2685221 QC1 tissue: Myocardium gender: male 4.828259
GSM2685222 QC2 tissue: Myocardium gender: male 3.4069712
GSM2685223 QC3 tissue: Myocardium gender: female 2.8050854
GSM2685224 QC4 tissue: Myocardium gender: female 3.163379

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 7.091272607
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 7.453115316
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 7.319231921
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.931504808
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.917235864
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 7.563858648

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 38.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 49.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 53.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 39.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 89.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 87.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 118.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 207.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 84.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 115.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 74.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 150.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 90.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 99.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 147.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 137.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 8.04199
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 8.084229
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 8.206561
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.133234
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.135503
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.933551

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 24.883
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 26.644
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 32.312
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 31.539
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 30.123

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 5.07169361
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 5.16000442
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 6.051873604

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 458.8
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 305.4
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 356.0
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 347.7
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 291.8
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 303.6
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 254.8
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 336.9
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 340.7
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 412.8
GSM27494 CTL_a (control, 1st replicate) 300.6
GSM27495 CTL_b (control, 2nd replicate) 291.1
GSM27496 CTL_c (control, 3rd replicate) 464.4
GSM27497 CTL_d (control, 4th replicate) 319.5
GSM27498 CTL_e (control, 5th replicate) 386.6
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 364.1
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 342.8
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 265.2
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 297.9
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 469.1
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 505.1
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 255.6
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 317.1
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 322.3
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 264.0
GSM27509 ISCH_a (ischemia, 1st replicate) 394.2
GSM27510 ISCH_b (ischemia, 2nd replicate) 384.6
GSM27511 ISCH_c (ischemia, 3rd replicate) 305.0
GSM27512 ISCH_d (ischemia, 4th replicate) 303.2
GSM27513 ISCH_e (ischemia, 5th replicate) 383.2

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 10.2
GSM30791 baseline control 02 male, 275-300g 14.9
GSM30792 baseline control 03 male, 275-300g 8.5
GSM30793 baseline control 04 male, 275-300g 15.6
GSM30794 baseline control 05 male, 275-300g 20.8
GSM30795 baseline control 06 male, 275-300g 13.0
GSM30796 baseline control 07 male, 275-300g 4.5
GSM30797 baseline control 08 male, 275-300g 20.3
GSM30798 baseline control 09 male, 275-300g 5.4
GSM30799 pain 01 5.0
GSM30800 pain 02 10.9
GSM30801 pain 03 68.2
GSM30802 pain 04 15.0
GSM30803 pain 05 11.7
GSM30804 FC 01 54.6
GSM30805 FC 02 51.3
GSM30806 FC 03 19.5
GSM30807 FC 04 18.9
GSM30808 FC 05 7.7
GSM30809 IFC 01 9.9
GSM30810 IFC 02 4.1
GSM30811 IFC 03 8.3
GSM30812 IFC 04 4.8
GSM30813 IFC 05 8.2
GSM99800 isoflurane 01 male, 275-300g 11.0
GSM99801 isoflurane 02 male, 275-300g 10.1
GSM99802 isoflurane 03 male, 275-300g 44.1
GSM99803 isoflurane 04 male, 275-300g 13.1
GSM99804 isoflurane 05 male, 275-300g 10.2

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 9.3738
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 7.166
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 8.4081
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 8.0776
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 8.686
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 8.7891
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 9.8062
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 7.8478
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 8.2214

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 10.0219
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 10.0363
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 7.98076
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 7.79388
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 11.5542
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 11.2371
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 11.2128
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 11.1706
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 9.10565
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 9.82573
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 6.90853
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 7.51873
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 10.6334
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 10.5214
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 10.1427
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 10.7065

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 3.972974
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 3.923828
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 3.886497
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 3.961725
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.031111
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 3.952841
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 3.940814
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.094604
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.05436
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 3.877064
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.062692
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.051903
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 3.981463
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 3.987698
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.00299
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 3.907422
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.015724
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.034922
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 3.921889
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 3.975526
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 3.8925
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 3.969416
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 3.977636
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 3.979883
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 3.973354
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.070289
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.06724
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 3.955052
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.11002
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.045383
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 3.963692
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.062997
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 3.975887
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 3.94788
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.048169
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.048032
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.068093
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.050216
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.00989
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 3.962869
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.008074
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.095798
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 3.857015
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.005145
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 3.957388

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 427.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 439.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 386.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 496.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 452.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 451.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 361.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 336.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 365.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 485.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 383.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 407.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 504.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 464.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 474.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 402.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 453.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 377.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 385.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 384.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 376.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 498.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 505.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 458.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 394.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 387.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 566.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 539.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 562.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 486.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 528.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 546.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 522.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 493.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 464.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 404.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 8.909198
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 9.38146
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 9.727599
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 10.924788

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.02905
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.05160000000000001
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0334
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.0596
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.0773
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0428
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.043745
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.04325
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0813
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.06598
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.013300000000000001
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.10955000000000001

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 123.0
GSM5121 Isoflurane single exposure control-2 80.2
GSM5122 Isoflurane single exposure control-3 129.6
GSM5124 Isoflurane single exposure 1 hr-1 123.0
GSM5126 Isoflurane single exposure 1 hr-2 140.2
GSM5127 Isoflurane single exposure 2 hr-1 129.8
GSM5130 Isoflurane single exposure 2 hr-2 178.9
GSM5131 Isoflurane single exposure 2 hr-3 131.6

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.173784767
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.36054383
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.193076876
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.248910264
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.277452699
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.330672303
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.481563711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.136077801
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.177347504
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.2228899
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.445357744
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.235314453
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.462881067
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.203168075
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.145412634
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.283772663
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.455912324
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.440294162
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.398682322
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.262867016
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.234288102
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.269160262
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.411768708
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.343455005

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.619489
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.682427
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.625919
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.650084
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.680456
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.516124
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.56589
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.636362
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.729389
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.611215
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.591575
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.469192
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.64419
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.605007
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.608861
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.461456
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.773873
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.666048
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.582028
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.599623
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.473551
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.664851
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.683849
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.61879

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 118.17869999999999
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 123.59625

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 8.481760195
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 9.200802456
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 30.12028102
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.551477502
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 14.15664858
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.14394731
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 51.05860484
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 63.92426971
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 7.671407039
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 28.50895152
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 13.34523482
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 16.35804276
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.79168018
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 51.59305761

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.173784767
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.36054383
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.193076876
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.248910264
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.277452699
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.330672303
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.481563711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.136077801
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.177347504
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.2228899
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.445357744
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.235314453
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.462881067
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.203168075
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.145412634
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.283772663
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.455912324
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.440294162
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.398682322
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.262867016
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.234288102
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.269160262
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.411768708
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.343455005
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 8.481760195
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 9.200802456
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 30.12028102
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.551477502
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 14.15664858
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.14394731
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 51.05860484
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 63.92426971
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 7.671407039
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 28.50895152
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 13.34523482
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 16.35804276
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.79168018
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 51.59305761

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 247.1
GSM5084 Control 2 222.3
GSM5085 Control 3 148.2
GSM5086 Control 4 249.5
GSM5087 Control 5 274.8
GSM5090 Control 6 265.5
GSM5105 Control 7 225.4
GSM5106 Control 8 195.2
GSM5107 Control 9 189.1
GSM5108 Halothane 10 exposure-1 170.0
GSM5109 Halothane 10 exposures-2 160.2
GSM5110 Halothane 10 exposures-3 152.0
GSM5111 Halothane 5 exposures-1 213.9
GSM5112 Halothane 5 exposures-2 207.8
GSM5113 Halothane 5 exposures-3 207.1
GSM5114 Isoflurane 10 exposures-1 144.7
GSM5115 Isoflurane 10 exposures-2 185.2
GSM5116 Isoflurane 10 exposures-3 161.2
GSM5117 Isoflurane 5 exposures-1 194.8
GSM5118 Isoflurane 5 exposures-2 191.9
GSM5119 Isoflurane 5 exposures-3 195.9
GSM11379 Control 10 194.6
GSM11380 Control 11 174.2
GSM11381 Control 12 211.5

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 1.5193
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 2.22907